Clinical trial NCT06124131: Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening
Official title: Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Health Behavior
Colorectal Cancer
Influenza
COVID-19
Vaccine Hesitancy
Vaccine-Preventable Diseases
Healthcare Patient Acceptance
Keywords: Cancer screening
Preventive healthcare
Vaccine uptake
Patient financial incentives
Federally qualified health center
Health services
Lead sponsor: Tulane University
Sponsor class: OTHER
Collaborators: name: National Heart, Lung, and Blood Institute (NHLBI)
First posted: 2023-11-09
Enrollment: 50
Sex: ALL
Minimum age (years): 45
Maximum age (years): 75
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: Participants will be randomly assigned to a study arm for the duration of their two months in the study
Primary purpose: SCREENING

Brief summary: The goal of this pilot clinical trial is to determine feasibility and explore whether financial incentives paid to primary care patients for completing colorectal cancer screening increase completion of colorectal cancer screening. The main questions it aims to answer are:

* Do patient financial incentives for completing colorectal cancer screening increase screening completion?
* Does a patient financial incentive for colorectal cancer screening offered alongside patient financial incentives for COVID-19 and flu shots increase completion of those shots?

Participants who are due for colorectal cancer screening will receive telephone outreach from primary care staff who will offer a stool-based colorectal cancer screening. Participants will be randomly assigned to either Group 1 or Group 2. Group 1 participants will be offered financial incentives for completing COVID-19 and flu shots within 2 months of enrollment. Group 2 participants will be offered financial incentives for completing a COVID-19 shot, a flu shot, and colorectal cancer screening within 2 months of enrollment.

Researchers will compare to see if completion of a COVID-19 shot, a flu shot, and colorectal cancer screening is different between the two groups.


Eligibility criteria: Inclusion Criteria:

* Age 45 to 75
* Receive care at participating primary care clinic
* Due for colorectal cancer screening
* Ability to understand and speak English

Exclusion Criteria:

* Currently participating in another clinical trial or research study on colorectal cancer screening
* Unable or unwilling to give informed consent

Primary outcomes:
measure: Difference in Percent of Participants Completing Colorectal Cancer Screening Between Study Arms
timeFrame: Two months
Secondary outcomes:
measure: Difference in Percent of Participants Completing COVID-19 Shot Between Study Arms
timeFrame: Two months
measure: Difference in Percent of Participants Completing Flu Shot Between Study Arms
timeFrame: Two months
measure: Difference in Percent of Participants Completing at Least One of the Following Services Between Study Arms: Colorectal Cancer Screening, COVID-19 Shot, Flu Shot
timeFrame: Two months
measure: Difference in Percent of Participants Completing All Three Services Between Study Arms: Colorectal Cancer Screening, COVID-19 Shot, Flu Shot
timeFrame: Two months
Other outcomes:
measure: Number of Patients Reached for Recruitment
timeFrame: Three months
measure: Number of Patients Assessed for Eligibility
timeFrame: Three months
measure: Number of Patients Consented and Randomized
timeFrame: Three months
measure: Number of Patients Who Receive the Outreach Call Intervention
timeFrame: Three months
Locations:
city: New Orleans
country: United States
facility: Tulane University School of Medicine
state: Louisiana
Study officials:
affiliation: Tulane University
name: Marie A Krousel-Wood, MD, MSPH
role: PRINCIPAL_INVESTIGATOR
References: